Mendelian randomization study on the effect of tumor necrosis factor on schizophrenia

aDepartment of Rheumatology, First Hospital of Jilin University, Changchun

bBeijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China

Received 9 May 2022 Accepted 4 October 2022.

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.psychgenetics.com.

Correspondence to Renxi Wang, Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, No. 10, Xitoutiao, You An Men, Beijing 100069, China, Tel: +8610 83950365; e-mail: [email protected]

留言 (0)

沒有登入
gif